Atai Life Sciences Net Profit Margin 2020-2024 | ATAI
Atai Life Sciences net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Atai Life Sciences Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $0.00B | $-0.13B | inf% |
| 2024-06-30 | $0.00B | $-0.06B | inf% |
| 2023-12-31 | $0.00B | $-0.04B | inf% |
| 2023-09-30 | $0.00B | $-0.07B | inf% |
| 2023-06-30 | $0.00B | $-0.15B | inf% |
| 2023-03-31 | $0.00B | $-0.15B | inf% |
| 2022-09-30 | $0.00B | $-0.20B | inf% |
| 2022-06-30 | $0.00B | $-0.19B | inf% |
| 2021-12-31 | $0.02B | $-0.17B | -835.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.200B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| LifeStance Health (LFST) | United States | $2.698B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |